Johnson & Johnson (JNJ) Key Statistics & Financial Ratios

Johnson & Johnson (JNJ) — Price $267.28 — Healthcare — Drug Manufacturers - General — NYSE

Latest reported results:

Key statistics dashboard for Johnson & Johnson (JNJ). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Stock Data

Price$267.28
Market Cap$644.1B
Enterprise Value$674.32B
Beta0.33
ExchangeNYSE
CountryUS

Valuation Multiples

P/E Ratio30.87
Price / Book7.67
P/S6.57
EV/EBITDA19.99
EV/Sales6.89
EV/FCF36.04
P/FCF34.40
Earnings Yield3.22%
FCF Yield2.90%
Dividend Yield1.98%

Profitability

Gross Margin67.91%
EBIT Margin26.53%
EBITDA Margin34.45%
Operating Margin26.81%
Net Margin21.48%
Return on Equity25.74%
Return on Assets10.46%
Return on Invested Capital13.89%
Return on Capital Employed17.96%

Financial Health

Current Ratio1.09
Quick Ratio0.81
Cash Ratio0.37
Debt / Equity0.58
Debt / Assets24.39%
Net Debt / EBITDA0.85
Interest Coverage25.94
Piotroski F-Score5
Altman Z-Score4.66

Per-Share Data

Revenue per share40.13
Book Value per share34.82
Cash per share8.51
FCF per share7.67
Tangible Book Value per share-4.81
Dividend per share5.28

Related companies: ABBV · AMGN · AZN · GILD · MRK · NVO · NVS

Explore sector: Healthcare · Drug Manufacturers - General

More sections of JNJ: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks